z-logo
open-access-imgOpen Access
1ISG-008 Economic impact of the use of biosimilar infliximab in a second-level hospital
Author(s) -
AB Morillo Mora,
V González Rosa,
MI Sierra Torres
Publication year - 2018
Publication title -
pubmed central
Language(s) - English
Resource type - Conference proceedings
DOI - 10.1136/ejhpharm-2018-eahpconf.8
Subject(s) - biosimilar , infliximab , medicine , pharmacy , observational study , vial , total cost , retrospective cohort study , hospital pharmacy , emergency medicine , family medicine , business , accounting , chemistry , disease

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom